Discovery of thienoimidazole-based HCV NS5A genotype 1a and 1b inhibitors

被引：0
|
作者：
Giroux, Simon [1 ]
Xu, Jinwang [1 ]
Reddy, T. Jagadeeswar [2 ]
Morris, Mark [1 ]
Cottrell, Kevin M. [1 ]
Cadilhac, Caroline [2 ]
Henderson, James A. [1 ]
Nicolas, Olivier [3 ]
Bilimoria, Darius [3 ]
Mani, Nagraj [4 ]
Ewing, Nigel [5 ]
Shawgo, Rebecca [5 ]
L'Heureux, Lucille [3 ]
Selliah, Subajini [3 ]
Grillot, Anne-Laure [1 ]
Bennani, Youssef L. [2 ]
Maxwell, John P. [1 ]
机构：
[1] Vertex Pharmaceut, Med Chem, Boston, MA 02210 USA
[2] Vertex Pharmaceut Canada Inc, Med Chem, Laval, PQ H7V 4A7, Canada
[3] Vertex Pharmaceut Canada Inc, Biol, Laval, PQ H7V 4A7, Canada
[4] Vertex Pharmaceut, Biol, Boston, MA 02210 USA
[5] Vertex Pharmaceut, Drug Metab & Pharmacokinet, Boston, MA 02210 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
79-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Investigating Genotype 1a HCV Drug Resistance in NS5A Region via Bayesian Inference
    Yao Fu
    Gang Chen
    Lizhi Fu
    Jing Zhang
    Tsinghua Science and Technology, 2015, 20 (05) : 484 - 490
  • [22] NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
    Bellocchi, Maria Concetta
    Aragri, Marianna
    Carioti, Luca
    Fabeni, Lavinia
    Pipitone, Rosaria Maria
    Brancaccio, Giuseppina
    Sorbo, Maria Chiara
    Barbaliscia, Silvia
    Di Maio, Velia Chiara
    Bronte, Fabrizio
    Grimaudo, Stefania
    Mazzucco, Walter
    Frigeri, Ferdinando
    Cantone, Marco
    Pinto, Antonio
    Perno, Carlo Federico
    Craxi, Antonio
    Gaeta, Giovanni Battista
    Di Marco, Vito
    Ceccherini-Silberstein, Francesca
    CELLS, 2019, 8 (07)
  • [23] NS5A gene analysis by next generation sequencing in HCV nosocomial transmission clusters of HCV genotype 1b infected patients
    Bellocchi, M. C.
    Carioti, L.
    Aragri, M.
    Fabeni, L.
    Pipitone, R.
    Brancaccio, G.
    Sorbo, M. C.
    di Maio, V. C.
    Bronte, F.
    Grimaudo, S.
    Rizzo, V.
    Frigeri, F.
    Cantone, M.
    Genderini, F.
    Pinto, A.
    Perno, C. F.
    Craxi, A.
    Gaeta, G. B.
    Di Marco, V.
    Ceccherini-Silberstein, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E62 - E62
  • [24] Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma
    Salpini, Romina
    Alkhatib, Mohammad
    Di Maio, Velia Chiara
    De Murtas, Valentina
    Aragri, Marianna
    Scutari, Rossana
    Sacco, Angelica
    Polilli, Ennio
    Masetti, Chiara
    Barbaliscia, Silvia
    Bertoli, Ada
    Cento, Valeria
    Calvaruso, Vincenza
    Morisco, Filomena
    Palitti, Valeria Pace
    Pasquazzi, Caterina
    Francioso, Simona
    Sozio, Federica
    Pieri, Alessandro
    Cacciatore, Pierluigi
    Babudieri, Sergio
    Teti, Elisabetta
    Mussini, Cristina
    Parruti, Giustino
    Borghi, Vanni
    Lenci, Ilaria
    Craxi, Antonio
    Andreoni, Massimo
    Mario, Angelico
    Maida, Ivana Rita
    Santoro, Maria
    Svicher, Valentina
    Perno, Carlo-Federico
    Silberstein, Francesca Ceccherini
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E699 - E700
  • [25] Discovery of potent HCV inhibitors targeting the NS5A protein
    Belema, Makonen
    Nguyen, Van N.
    Romine, Jeffrey L.
    St Laurent, Denis R.
    Serrano-Wu, Michael H.
    Snyder, Lawrence B.
    Deshpande, Milind S.
    Fridell, Robert A.
    O'Boyle, Donald R., II
    Lemm, Julie A.
    Leet, John E.
    Knipe, Jay O.
    Langley, David R.
    Nettles, Richard E.
    Chien, Caly
    Colonno, Richard J.
    Grasela, Dennis M.
    Meanwell, Nicholas A.
    Hamann, Lawrence G.
    Gao, Min
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [26] Mutations in the NS5A region and response to interferon in HCV genotype 3a and 1a infection.
    Bell, SJ
    Locarnini, SA
    Watson, KJ
    Desmond, PV
    Bartholomeusz, AI
    GASTROENTEROLOGY, 1997, 112 (04) : A1224 - A1224
  • [27] Effects of Resistance Mutations of NS5A Inhibitor on Viral Production and Susceptibility to Anti-HCV Reagents in Recombinant Hepatitis C Viruses with NS5A of Genotype 1b
    Nitta, Sayuri
    Asahina, Yasuhiro
    Wakita, Takaji
    Kato, Takanobu
    HEPATOLOGY, 2015, 62 : 692A - 692A
  • [28] INFLUENCE OF HCV GENOTYPE 1A AND GENOTYPE 1B ON THE VIROLOGICAL RESPONSE TO ANTIVIRAL THERAPY
    Pellicelli, Adriano M.
    Romano, Mario
    Barbarini, Giorgio
    Mazzoni, Ettore
    Mecenate, Fabrizio
    Furlan, Caterina
    Picardi, Antonio
    Bonaventura, Maria Elena
    Barbaro, Giuseppe
    Villani, Roberto
    D'Ambrosio, Cecilia
    Guarascio, Paolo
    Fondacaro, Lucia
    Cerasari, Giuseppe
    Lusi, Angela Elena
    Andreoli, Arnaldo
    Soccorsi, Fabrizio
    HEPATOLOGY, 2010, 52 (04) : 795A - 795A
  • [29] Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b
    Alkhatib, Mohammad
    Di Maio, Velia Chiara
    De Murtas, Valentina
    Polilli, Ennio
    Milana, Martina
    Teti, Elisabetta
    Fiorentino, Gianluca
    Calvaruso, Vincenza
    Barbaliscia, Silvia
    Bertoli, Ada
    Scutari, Rossana
    Carioti, Luca
    Cento, Valeria
    Santoro, Maria Mercedes
    Orro, Alessandro
    Maida, Ivana
    Lenci, Ilaria
    Sarmati, Loredana
    Craxi, Antonio
    Pasquazzi, Caterina
    Parruti, Giustino
    Babudieri, Sergio
    Milanesi, Luciano
    Andreoni, Massimo
    Angelico, Mario
    Perno, Carlo Federico
    Ceccherini-Silberstein, Francesca
    Svicher, Valentina
    Salpini, Romina
    VIRUSES-BASEL, 2021, 13 (05):
  • [30] Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors
    Pham, Long V.
    Ramirez, Santseharay
    Carlsen, Thomas H. R.
    Li, Yi-Ping
    Gottwein, Judith M.
    Bukh, Jens
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
12345